Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 27, 505 (1 June 2009) | doi:10.1038/nbt0609-505
Reply to Conflating MTAs and patents
Abstract
Zhen Lei and Brian D. Wright reply: To a reader unfamiliar with intellectual property (IP), Noonan's thesis might well be persuasive. Researchers have problems with material transfer agreements (MTAs), not patents.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
